CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in OGN — Organon & Co.
CIK 884546
SAN FRANCISCO, CA
Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,811,327
+$26,670,857 QoQ
Shares Held
3,457,262
+2.8% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $34,394,076,697 across 15 Drug Manufacturers - General names. OGN ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,001,955 | $7,198,925,485 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,365,289 | $6,985,939,635 | |
| 3 | AMGN |
Amgen Inc
|
15,034,038 | $5,444,125,839 | |
| 4 | JNJ |
Johnson & Johnson
|
19,126,165 | $4,857,472,124 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,595,177 | $3,894,834,098 | |
| 6 | ABBV |
AbbVie Inc.
|
12,914,230 | $3,249,736,836 | |
| 7 | PFE |
Pfizer Inc
|
52,548,228 | $1,265,361,329 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,155,281 | $1,030,338,200 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,811,327 | 3,457,262 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,140,470 | 3,362,349 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,841,526 | 2,906,768 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,220,695 | 3,110,552 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $34,687,137 | 3,583,382 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $49,343,866 | 3,313,893 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $49,738,848 | 3,333,703 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $63,569,965 | 3,323,051 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $50,672,006 | 2,447,923 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $46,018,621 | 2,447,799 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $32,919,403 | 2,282,899 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $41,406,672 | 2,385,177 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $46,015,072 | 2,211,200 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $50,740,260 | 2,157,324 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $52,818,674 | 1,891,109 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $42,802,624 | 1,829,172 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $60,125,051 | 1,781,483 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,460,033 | 1,759,520 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $134,756,627 | 4,425,505 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $139,296,149 | 4,248,129 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $118,938,261 | 3,930,544 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||